NCT05702229 2026-03-18Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaAstraZenecaPhase 2 Recruiting163 enrolled
NCT07334431 2026-01-12Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric CancerHenan Cancer HospitalPhase 1/2 Recruiting45 enrolled
NCT06128252 2025-01-07Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric CancerTang-Du HospitalPhase NA Recruiting96 enrolled
NCT05494060 2023-11-07EXPLORINGThe First Affiliated Hospital with Nanjing Medical UniversityPhase 2 Recruiting80 enrolled
NCT05264896 2023-09-07Perioperative FLOT vs Adjuvant XELOX for CA StomachChinese University of Hong KongPhase 3 Recruiting110 enrolled